Cargando…
Radiopharmacologist’s and Radiochemist’s View on Targeting the Eph/Ephrin Receptor Tyrosine Kinase System
[Image: see text] In the past decade, there have been extensive efforts to open up the Eph/ephrin subfamily of the receptor tyrosine kinase family for diagnostic and therapeutic applications. Besides classical pharmaceutical developments, which focus either on drugs targeting the extracellular ligan...
Autores principales: | Neuber, Christin, Belter, Birgit, Mamat, Constantin, Pietzsch, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364440/ https://www.ncbi.nlm.nih.gov/pubmed/32685795 http://dx.doi.org/10.1021/acsomega.0c01058 |
Ejemplares similares
-
Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
por: Mosch, Birgit, et al.
Publicado: (2010) -
Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments (‡)
por: Neuber, Christin, et al.
Publicado: (2018) -
The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts
por: Neuber, Christin, et al.
Publicado: (2020) -
Eph receptors and ephrins as targets for cancer therapy
por: Xi, Hong-Qing, et al.
Publicado: (2012) -
Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase
Activation
por: Giorgio, Carmine, et al.
Publicado: (2011)